Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Y Graeber

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 1, 2014
Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung diseaseStefanie Gehrig, Julia Duerr, Michael Weitnauer, et al.
Frontiers in Microbiology|May 31, 2022
Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic FibrosisDario L Frey, Calum Bridson, Susanne Dittrich, et al.
Annals of the American Thoracic Society|February 18, 2021
Effects of Lumacaftor-Ivacaftor on Lung Clearance Index, Magnetic Resonance Imaging, and Airway Microbiome in Phe508del Homozygous Patients with Cystic FibrosisSimon Y Graeber, Sébastien Boutin, Mark O Wielpütz, et al.
Frontiers in Medicine|January 23, 2023
TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung diseaseEva Steinke, Olaf Sommerburg, Simon Y Graeber, et al.
Angewandte Chemie (International Ed. in English)|December 22, 2025
Chemical Synthesis of Pseudomonas aeruginosa, Staphylococcus aureus, and Acinetobacter baumannii Capsular Polysaccharide Fragments as Leads for Cross-ProtectionAmar Kumar Mishra, Emelie E Reuber, Diksha Rai, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 12, 2021
Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosisDario L Frey, Sébastien Boutin, Susanne A Dittrich, et al.
Plos One|January 29, 2015
Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosisSébastien Boutin, Simon Y Graeber, Michael Weitnauer, et al.
International Journal of Molecular Sciences|August 12, 2023
Personalized CFTR Modulator Therapy for <i>G85E</i> and <i>N1303K</i> Homozygous Patients with Cystic FibrosisSimon Y Graeber, Anita Balázs, Niklas Ziegahn, et al.
The European Respiratory Journal|September 18, 2025
Changes in Sputum Viscoelastic Properties and Airway Inflammation in Primary Ciliary Dyskinesia are Comparable to Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor TherapyHannah Nussstein, Ruth M Urbantat, Kerstin Fentker, et al.
Biomaterials Science|July 19, 2024
Thiolated polyglycerol sulfate as potential mucolytic for muco-obstructive lung diseasesJustin Arenhoevel, Aditi Kuppe, Annalisa Addante, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
American Journal of Respiratory and Critical Care Medicine|April 1, 2014
Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung diseaseStefanie Gehrig, Julia Duerr, Michael Weitnauer, et al.
Frontiers in Microbiology|May 31, 2022
Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic FibrosisDario L Frey, Calum Bridson, Susanne Dittrich, et al.
Annals of the American Thoracic Society|February 18, 2021
Effects of Lumacaftor-Ivacaftor on Lung Clearance Index, Magnetic Resonance Imaging, and Airway Microbiome in Phe508del Homozygous Patients with Cystic FibrosisSimon Y Graeber, Sébastien Boutin, Mark O Wielpütz, et al.
Frontiers in Medicine|January 23, 2023
TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung diseaseEva Steinke, Olaf Sommerburg, Simon Y Graeber, et al.
Angewandte Chemie (International Ed. in English)|December 22, 2025
Chemical Synthesis of Pseudomonas aeruginosa, Staphylococcus aureus, and Acinetobacter baumannii Capsular Polysaccharide Fragments as Leads for Cross-ProtectionAmar Kumar Mishra, Emelie E Reuber, Diksha Rai, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 12, 2021
Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosisDario L Frey, Sébastien Boutin, Susanne A Dittrich, et al.
Plos One|January 29, 2015
Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosisSébastien Boutin, Simon Y Graeber, Michael Weitnauer, et al.
International Journal of Molecular Sciences|August 12, 2023
Personalized CFTR Modulator Therapy for <i>G85E</i> and <i>N1303K</i> Homozygous Patients with Cystic FibrosisSimon Y Graeber, Anita Balázs, Niklas Ziegahn, et al.
The European Respiratory Journal|September 18, 2025
Changes in Sputum Viscoelastic Properties and Airway Inflammation in Primary Ciliary Dyskinesia are Comparable to Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor TherapyHannah Nussstein, Ruth M Urbantat, Kerstin Fentker, et al.
Biomaterials Science|July 19, 2024
Thiolated polyglycerol sulfate as potential mucolytic for muco-obstructive lung diseasesJustin Arenhoevel, Aditi Kuppe, Annalisa Addante, et al.
Pageof 6